The global orphan and rare dermatology premium products market is expected to grow rapidly from $1.64 billion in 2017 to...
With its newly founded, independent Life Science Factory, Sartorius, a leading international partner of the biopharmaceu...
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...
Roche Diagnostics and the University of Indianapolis are partnering to create a custom talent pipeline for biomedical eq...
SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharm...
ImaginAb, Inc., an immuno-oncology imaging company, and Centre for Probe Development and Commercialization (CPDC), a Can...
Singapore - In February 2019, the Delegated Regulation to the Falsified Medicines Directive (FMD) comes legally into for...
Singapore – CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple th...
Singapore - Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic co...
Singapore - Patrys Limited and the Walter and Eliza Hall Institute of Medical Research have recently been awarded a...
Eisai Inc. recently announced that results from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients trea...
The main reasons why people die after non-cardiac surgery are revealed in a study of more than 40,000 patients from six ...
Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, has uncovered an anticoagulant treatment str...
The British Heart Foundation (BHF) has launched the Big Beat Challenge, a unique research funding award that will bring ...
Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, ...
GT Biopharma Inc. (GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company'...
Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...
